CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online 2016 September 25 DOI: https://doi.org/10.3350/cmh.2016.0047

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clinical and Molecular Hepatology. 2016;22(3):382-389

Link1

Link2 Link3

The impact of early hepatitis B virus viral suppression on treatment response in entecavir‐treated hepatitis B e antigen‐positive chronic hepatitis B

Yi‐Jie Huang, Chi‐Sen Chang, Hong‐Zen Yeh, Sheng‐Shun Yang, Chung‐Hsin Chang

Advances in Digestive Medicine. 2023;

Link1 Link2

Rely to: ‘Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues’

Ya‐Chao Tao, En‐Qiang Chen

Journal of Viral Hepatitis. 2020;28(1):221-222

Link1 Link2 Link3

Sustained response after a 2-year course of lamivudine treatment of hepatitis B e antigen-negative chronic hepatitis B

S. K. Fung, F. Wong, M. Hussain, A. S. F. Lok

Journal of Viral Hepatitis. 2004;11(5):432-438

Link1 Link2

Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B

Cheng-Yuan Peng, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Ching-Hsiang Chen

Scientific Reports. 2017;7(1):

Link1 Link2

Link3

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naÃ¯ve HBeAg-positive patients with chronic hepatitis B*

R. G. Gish, T.-T. Chang, C.-L. Lai, R. De Man, A. Gadano, F. Poordad, J. Yang, H. Brett-Smith, R. Tamez

Journal of Viral Hepatitis. 2010;17(1):16-22

Link1 Link2

Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment

James Fung, Ching-Lung Lai, John Young, Danny Ka-Ho Wong, John Yuen, Wai-Kay Seto, Man-Fung Yuen

American Journal of Gastroenterology. 2011;106(10):1766-1773

Link1

Link2 Link3

Link4

Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues

Jing Chen, Yong Wang, Jiayu Wu

Journal of Viral Hepatitis. 2020;27(12):1511-1511

Link1 Link2 Link3

Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir

C. Q. Pan, K.-Q. Hu, A. S. Yu, W. Chen, C. Bunchorntavakul, K. R. Reddy

Journal of Viral Hepatitis. 2011;19(3):213-219

Link1 Link2

Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring

S. Lobello, U. Lorenzoni, A. Vian, A. Floreani, M. R. Brunetto, M. Chiaramonte

Journal of Viral Hepatitis. 1998;5(1):61-66

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.